News & Events - Page 7 of 21 - Bay City Capital

Filters

Portfolio News

October 20, 2016

Madrigal Pharmaceuticals Announces the Initiation of a Phase 2 Study of MGL-3196 in NASH Patients

Portfolio News

October 19, 2016

Merus Receives Milestone Payment from Ono Pharmaceutical for Selection of Bispecific Antibody

Bay City Capital News

October 18, 2016

David Beier on Building Government Trust

Bay City Capital News

October 13, 2016

David Beier in Forbes: Drug Prices Reflect More Than Development Costs

How Bad Is The Drug Industry's Reputation After Pricing Kerfuffles?

Portfolio News

October 11, 2016

Cydan Announces the Promotion of James McArthur, Ph.D. to President, Research and Development

Bay City Capital News

September 30, 2016

David Beier in The Hill: Stopping Puerto Rico’s Zika Crisis

Portfolio News

September 19, 2016

EnteroMedics Announces Receipt of Notice of Intention to Grant European Patent

Portfolio News

September 15, 2016

Epizyme Earns $6 Million Milestone Payment from GlaxoSmithKline

Events

September 14, 2016

Alexandria Summit – Healthcare Economics 2016

David Beier
September 14-15, 2016
New York, NY

Bay City Capital News

September 14, 2016

David Beier in Forbes Op Ed: A Bipartisan Health Care Platform for 2017

Clinton and Trump: Common Ground on Health Policy

Portfolio News

September 6, 2016

Nevro Announces Two-Year SENZA-RCT Results in Neurosurgery

Bay City Capital News

August 24, 2016

First Closing Of The Earlybird Health Tech Fund

Portfolio News

August 3, 2016

Interleukin Genetics Strengthens Commercial Leadership with Key Appointments

Portfolio News

August 1, 2016

Interleuken Genetics Announces $5.6M Financing

Portfolio News

July 26, 2016

Vtesse Secures Additional $17M in Series A Extension